Shantou University Medical College Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01670409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Affiliated Cancer Hospital of Shantou University Medical College | Affiliated Cancer Hospital of Shantou University Medical College Medical | Chuangzhen Chen